Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03572296
Other study ID # HVS-010
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 25, 2018
Est. completion date January 28, 2019

Study information

Verified date January 2019
Source Lucozade Ribena Suntory
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postprandial glycaemia refers to the transient rise in blood glucose levels that occurs after consuming a meal. Large fluctuations in blood glucose levels, experienced on a frequent basis, may impair the functioning of pancreatic beta cells, and thus elevate the risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease. Our group has previously shown that consuming a drink containing fruit polyphenols immediately before a meal, may reduce postprandial glycaemia. Importantly, other fruit components, namely soluble fibres, also impact on carbohydrate digestion by slowing gastric emptying rates. Combining fruit polyphenols and fibre in a drink may, potentially, have additive or synergistic effects on reducing postprandial glycaemia.

This study will investigate the effects of drinks containing blackcurrant polyphenol extract combined with pulp (source of fibre), and pulp alone, on postprandial outcomes and cognitive function following a mixed carbohydrate (starch and sucrose) test meal.


Description:

Intake of carbohydrate-rich foods transiently increases blood glucose levels (known as postprandial glycaemia). Repeated, high, postprandial glucose responses are evidenced to impair pancreatic beta cell function, thus increasing the risk of developing type-2 diabetes mellitus and cardiovascular disease. Therefore, meals that elicit a reduced, or more gradual, rise in blood glucose levels are desirable.

Previous studies have shown that consuming a drink containing fruit polyphenols, such as those from blackcurrants (BC), immediately before a high carbohydrate meal, reduced the postprandial glycaemic response. Importantly, other fruit components, namely soluble fibres, also impact on carbohydrate digestion by slowing gastric emptying rates. It is not yet known the effect of combining fibre and polyphenols on postprandial glycaemia. Although limited, there is a growing body of evidence showing beneficial acute effects of polyphenols in cognitive function which is of great interest in many work and academic environments where fast cognitive enhancement is wanted to perform a task or an exam.

This study will investigate the effects of drinks containing BC polyphenol extract combined with pulp (source of fibre), and pulp alone, on postprandial outcomes and cognitive function following a mixed carbohydrate (starch and sucrose) test meal.

Study design: A randomised, controlled, double-blind, cross-over study, of the healthy adult UK population, will be conducted. All subjects will receive the placebo drink, pulp only drink and the pulp with polyphenol drink in a random order. Baseline (fasted) blood samples will be taken before consuming the test drink (T0 min). Immediately following consumption of the drink, a mixed carbohydrate test meal will be consumed. Further blood samples will be collected at regular times until T150 min. Blood samples will be analysed for plasma glucose, insulin, glucose-dependent insulinotropic peptide (GIP) and C-peptide. Subjects will also perform a 30 min computer based cognitive performance test at baseline (T-45 min) and endpoint (T165 min). Visual analogue scales will be used to assess the effect of the test drinks on a range of sensory characteristics e.g. palatability, satiety and subjective mood feelings. Finally, an ad libitum pasta meal at the end of the study visit (T 215 min) will be used to assess the effects on energy intake.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date January 28, 2019
Est. primary completion date January 28, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Age: 18-70 years

- Men and women

- Healthy (free of diagnosed diseases listed in the exclusion criteria)

- Body Mass Index 18-35 kg/m2

- Able to understand the information sheet and willing to comply with study protocol

- Able to give informed written consent

Exclusion Criteria:

- Those diagnosed with Phenylketonuria (PKU)

- Those with known or suspected food intolerances, allergies or hypersensitivity

- Women who are known to be pregnant or who are intending to become pregnant over the course of the study

- Women who are breastfeeding

- Participation in another clinical trial

- Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.

- Full Blood Counts and Liver Function test results outside of the normal range.

- Current smokers, or reported giving up smoking within the last 6 months

- History of substance abuse or alcoholism

- Reported history of Cardiovascular disease, diabetes (or fasting glucose = 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function

- Unwilling to restrict consumption of specified high polyphenol/ high fibre foods for 48 h before the study

- Weight change >3 kg in preceding 2 months

- Blood pressure =160/100 mmHg

- Total cholesterol = 7.5 mmol/L; fasting triacylglycerol concentrations = 5.0 mmol/L

- Medications that may interfere with the study: alpha-glucosidase inhibitors (acarbose: Glucobay), insulin sensitizing drugs (metformin: Glucophage, Glucophage SR, Eucreas, Janumet; thiazolidinediones: Actos, Competact), sulfonylureas (Daonil, Diamicron, Diamicron MR, Glibenese, Minodiab, Amaryl Tolbutamide), and lipid lowering drugs (statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates). Other medications should be reviewed by medical representative from KCL on a case by case basis.

- Nutritional supplements that may interfere with the study: higher dose vitamins/minerals (>200% Recommend Nutrient Intake), B vitamins, Vitamin C, calcium, copper, chromium, iodine, iron, magnesium, manganese, phosphorus, potassium and zinc. Subjects already taking vitamin or minerals at a dose around 100% or less up to 200% of the RNI, or evening primrose/algal/fish oil supplements will be asked to maintain habitual intake patterns, ensuring that they take them every day and not sporadically. They will be advised not to stop taking supplements or start taking new supplements during the course of the study.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Placebo
Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.
Polyphenol and fibre
Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.
Fibre
Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.

Locations

Country Name City State
United Kingdom Metabolic Research Unit London

Sponsors (2)

Lead Sponsor Collaborator
Lucozade Ribena Suntory King's College London

Country where clinical trial is conducted

United Kingdom, 

References & Publications (1)

Castro-Acosta ML, Smith L, Miller RJ, McCarthy DI, Farrimond JA, Hall WL. Drinks containing anthocyanin-rich blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations. J Nutr Biochem. 2016 Dec;38:154-161. doi: 10.1016/j.jnutbio.2016.09.002. Epub 2016 Sep 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other 7-d food diary (estimated/unweighed) Habitual dietary intake analysis 7-days
Other 100 mm visual analogue scale (VAS) measures of the palatability of the study drink For each VAS, a numerical score between 0 (not at all) and 100 (extremely) mm was obtained. 10 min following the test drink
Other 100 mm visual analogue scale (VAS) measures of mood, satiety and digestive comfort For each VAS, a numerical score between 0 (not at all) and 100 (extremely) mm was obtained. 150 min
Other Ad libitum energy intake Energy intake during ad libitum meal 15 min
Other 100 mm visual analogue scale (VAS) measures of the palatability of the ad libitum meal For each VAS, a numerical score between 0 (not at all) and 100 (extremely) mm was obtained. 15 min following the ad libitum meal
Other Buccal mouth swab Future exploratory analysis of lactase activity via the derived allele at the European One off sample, collected at the first 1 day of study visit
Primary Postprandial glycaemia (iAUC 0-30 min) The primary endpoint is iAUC 0-30 min for plasma glucose concentrations 30 min
Secondary Postprandial glycaemia: iAUC 0-120 min iAUC 0-120 min for plasma glucose concentrations 120 min
Secondary Postprandial glycaemia: iAUC 0-150 min iAUC 0-150 min for plasma glucose concentrations 150 min
Secondary Postprandial glycaemia: iCmax iCmax for plasma glucose concentrations 150 min
Secondary Postprandial glycaemia: Tmax Tmax for plasma glucose concentrations 150 min
Secondary Postprandial glycaemia: absolute concentrations at specific time points Absolute concentrations at specific time points, for plasma glucose concentrations 150 min
Secondary Postprandial insulinemia: iAUC 0-30 min iAUC 0-30 min for serum insulin concentrations 30 min
Secondary Postprandial insulinemia: iAUC 0-120 min iAUC 0-120 min for serum insulin concentrations 120 min
Secondary Postprandial insulinemia: iAUC 0-150 min iAUC 0-150 min for serum insulin concentrations 150 min
Secondary Postprandial insulinemia: iCmax iCmax, for serum insulin concentrations 150 min
Secondary Postprandial insulinemia: Tmax Tmax for serum insulin concentrations 150 min
Secondary Postprandial insulinemia: absolute concentrations at specific time points Absolute concentrations at specific time points, for serum insulin concentrations 150 min
Secondary Postprandial C-peptide: iAUC 0-30 min iAUC 0-30 min for plasma C-peptide concentrations 30 min
Secondary Postprandial C-peptide: iAUC 0-120 min iAUC 0-120 min for plasma C-peptide concentrations 120 min
Secondary Postprandial C-peptide: iAUC 0-150 min iAUC 0-150 min for plasma C-peptide concentrations 150 min
Secondary Postprandial C-peptide: iCmax iCmax for plasma C-peptide concentrations 150 min
Secondary Postprandial C-peptide: Tmax Tmax for plasma C-peptide concentrations 150 min
Secondary Postprandial C-peptide: Absolute concentrations at specific time points Absolute concentrations at specific time points, for plasma C-peptide concentrations 150 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-30 min iAUC 0-30 min for plasma GIP concentrations 30 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-120 min iAUC 0-120 min for plasma GIP concentrations 120 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-150 min iAUC 0-150 min for plasma GIP concentrations 150 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): iCmax iCmax, for plasma GIP concentrations 150 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): Tmax Tmax for plasma GIP concentrations 150 min
Secondary Postprandial blood glucose-dependent insulinotropic peptide (GIP): Absolute concentrations at specific time points Absolute concentrations at specific time points, for plasma GIP concentrations 150 min
Secondary Cognitive function test scores Descriptive statistics Before and after 150 min blood collection
See also
  Status Clinical Trial Phase
Completed NCT03184064 - Acute Effects of Blackcurrant and Citrus Polyphenol Extracts on Postprandial Glycaemia N/A
Completed NCT03994276 - The Postprandial Effects of Chick-Pea Consumption on Glucose, Insulin, and Gut Hormone Responses (PEA-POD). N/A
Completed NCT01618071 - Vascular Effects of Triglyceride-rich Lipoproteins N/A
Recruiting NCT06231706 - ZOE BIOME Study: Biotics Influence on Microbiome Ecosystem N/A
Completed NCT04989478 - Postprandial Metabolism in Healthy Young Subjects N/A